| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2002 | US6417225 Hydroquinone derivative |
| 07/09/2002 | US6417224 Prophylactic, therapeutic agent for osteoporosis |
| 07/09/2002 | US6417223 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof |
| 07/09/2002 | US6417221 Tropane analogs and methods for inhibition of monoamine transport |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417217 Prolines as antimicrobial agents |
| 07/09/2002 | US6417215 Calcilytic compounds |
| 07/09/2002 | US6417214 Compounds as contraceptives |
| 07/09/2002 | US6417212 Modulators of peroxisome proliferator activated receptors |
| 07/09/2002 | US6417210 Mixture for treatment of parkinson's disease |
| 07/09/2002 | US6417209 Heterocyclic ketone and thioester compounds and uses |
| 07/09/2002 | US6417207 Potassium channel activator for cardiovascular disorders |
| 07/09/2002 | US6417206 Antitussive/antihist aminic/decongestant compositions |
| 07/09/2002 | US6417205 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 07/09/2002 | US6417204 Cardiovascular disoders |
| 07/09/2002 | US6417201 Levobupivacaine as an analgesic agent |
| 07/09/2002 | US6417200 Antithrombotic agents |
| 07/09/2002 | US6417199 3-benzyl-benzothiophenes |
| 07/09/2002 | US6417198 Benzothiazole ketone derivatives for nervous system disorders such as cognition activators |
| 07/09/2002 | US6417197 Prodrugs formed with esterification and acidification |
| 07/09/2002 | US6417196 Stabilization of quinapril using magnesium oxide |
| 07/09/2002 | US6417194 Quinolines and quinazolines useful in therapy |
| 07/09/2002 | US6417193 Methods for inhibiting MRP1 |
| 07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/09/2002 | US6417191 Synergistic combinations of zidovudine, 1592U89 and 3TC |
| 07/09/2002 | US6417190 Enzyme inhibitors |
| 07/09/2002 | US6417189 Drugs with pyrazole ketone derivatives |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417186 Substituted-phenyl ketone derivatives as IP antagonists |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6417183 1,4-diazacycloheptane derivatives |
| 07/09/2002 | US6417182 Pharmaceutical compositions comprising metal complexes |
| 07/09/2002 | US6417181 Viricides formed by catalytic hydrogenation |
| 07/09/2002 | US6417180 Zinc finger-reactive antimicrobial compounds |
| 07/09/2002 | US6417178 Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
| 07/09/2002 | US6417177 Chloroquine derivatives for the treatment of Parkinson's disease |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417175 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 07/09/2002 | US6417174 Inhibitors of β-lactamases and uses therefor |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417172 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 07/09/2002 | US6417160 Cell survival for diabetes for treatment of diabetic neuropathy |
| 07/09/2002 | US6417010 Methods and apparatus for synthesizing labeled combinatorial chemistry libraries |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416979 5-substituted picolinic acid compounds production by Marasmiellus sp |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416964 Contacting putative activity-modifying agent selected from organic biphosphonates, anti beta3 integrin monoclonal antibody, echistatin, calcitonin and other with a cell culture, determining the kinase activity of the cell culture |
| 07/09/2002 | US6416947 Vaccine adjuvant and vaccine method |
| 07/09/2002 | US6416808 Method of obtaining a hydroxytyrosol-rich composition from vegetation water |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416793 Adding solubilizing emulsifier, adding solvent and surfactant, dissolving one or more phytochemicals, adding encapsulator, mixing to produce microdispersion, spray drying |
| 07/09/2002 | US6416791 Potassium bicarbonate and ribose |
| 07/09/2002 | US6416785 Molecular probes for targeting of cell density-indicating compounds |
| 07/09/2002 | US6416783 Aspartic and malic acid inhibition of ss-glucuronidase |
| 07/09/2002 | US6416780 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 07/09/2002 | US6416779 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 07/09/2002 | US6416778 Pharmaceutical preparations and methods for their regional administration |
| 07/09/2002 | US6416773 Cosmetic or dermatological light protection agent preparations |
| 07/09/2002 | US6416767 Use of peroxidized lipids as agents intended to prevent and/or to treat the irritant effects of an active principle |
| 07/09/2002 | US6416760 Therapeutic/cosmetic formulation for therapeutical treatment or care of sensitive human skin, hair, mucous membrane, nails and/or the scalp comprises a calcitonin gene related peptide (cgrp) antagonist and a carrier, diluent or vehicle |
| 07/09/2002 | US6416749 Treatment for onychomycosis topically applying salicylic acid, optionally in combination with a retinoid |
| 07/09/2002 | US6416743 Nontoxic, stable formulation free of chlorofluorocarbons; surfactant and excipient free |
| 07/09/2002 | US6416737 Increasing bone strength with selected bisphosphonates |
| 07/09/2002 | US6415797 Treatment of human herpesviruses using hyperthermia |
| 07/09/2002 | CA2366766A1 Glycoprotein matrix compositions and methods related thereto |
| 07/09/2002 | CA2328831A1 Antibiotics as quorum-sensing autoinducers |
| 07/09/2002 | CA2303132C Intranasal formulations containing scopolamine and method of treating motion sickness |
| 07/09/2002 | CA2273420C Matrix tablet permitting sustained release of gliclazide after oral administration |
| 07/09/2002 | CA2270124C 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin |
| 07/09/2002 | CA2244519C C-4":substituted macrolide antibiotics |
| 07/09/2002 | CA2229624C Method of reducing bodyweight and treating obesity |
| 07/09/2002 | CA2221592C Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction |
| 07/09/2002 | CA2219475C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/09/2002 | CA2217455C New substituted derivatives, of biphenyl or phenylpiridine, their preparation process and the pharmaceutical compositions that contain them |
| 07/09/2002 | CA2211444C New benzimidazol, benzoxazol and benzothiazol derivitives, the procedure for preparing them and the pharmaceutical compositions which contain them. |
| 07/09/2002 | CA2191993C Novel synthesis of 19-nor-vitamin d compounds |
| 07/09/2002 | CA2133218C Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase |
| 07/09/2002 | CA2094137C Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
| 07/09/2002 | CA2091343C Process for preparing formoterol and related compounds |
| 07/09/2002 | CA2061566C Treatment of disease employing hyaluronic acid and nsaids |
| 07/09/2002 | CA2048212C Sulfonamide derivatives |
| 07/09/2002 | CA2041224C Azatetracycle compounds |
| 07/09/2002 | CA2036307C 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method |
| 07/09/2002 | CA2026763C Cosmetic or pharmaceutical composition for topical use, comprising at least one retinoid derivation and at least one pyrimidine derivative, use of same for medical purpose, and method of using same |
| 07/09/2002 | CA2024916C Respiratory disorder medicaments comprising salmeterol and fluticasone propionate |
| 07/09/2002 | CA2024872C Medicaments |
| 07/05/2002 | CA2363901A1 Estrogen receptors |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051855A2 Motilide compounds |
| 07/04/2002 | WO2002051851A2 Pharmaceutical uses and synthesis of benzobicyclooctanes |